Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/57959, first published .
Effectiveness and Acceptability of Targeted Text Message Reminders in Colorectal Cancer Screening: Randomized Controlled Trial (M-TICS Study)

Effectiveness and Acceptability of Targeted Text Message Reminders in Colorectal Cancer Screening: Randomized Controlled Trial (M-TICS Study)

Effectiveness and Acceptability of Targeted Text Message Reminders in Colorectal Cancer Screening: Randomized Controlled Trial (M-TICS Study)

Original Paper

1Cancer Screening Unit, Institut Català d’Oncologia (ICO), L'Hospitalet de Llobregat, Spain

2Early Detection of Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain

3School of Health Sciences, University of Dundee, Dundee, United Kingdom

4Ciber Salud Pública (CIBERESP), Instituto Salud Carlos III, Madrid, Spain

5Department of Economics, University Rovira i Virgili, Reus, Spain

6Research Group Economic Challenges for the Next Generation (ECO-NEXT), Reus, Spain

7Research Center on Economics and Sustainability (ECO-SOS), Reus, Spain

8Gastroenterology Department, Bellvitge University Hospital, L’Hospitalet de Llobregat, Spain

9Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute, L’Hospitalet de Llobregat, Spain

10Vall d' Hebron University Hospital, Barcelona, Spain

11See Acknowledgments

Corresponding Author:

Montse Garcia, PhD

Cancer Screening Unit

Institut Català d’Oncologia (ICO)

Gran Via de L'Hospitalet 199-203

L'Hospitalet de Llobregat, 08908

Spain

Phone: 34 932607210 ext 3104

Email: mgarcia@iconcologia.net


Background: Mobile phone–based SMS text message reminders have the potential to improve colorectal cancer screening participation rates.

Objective: This study assessed the effectiveness and acceptability of adding targeted SMS text message reminders to the standard procedure for those who picked up but did not return their screening kit at the pharmacy within 14 days in a colorectal cancer screening program in Catalonia, Spain.

Methods: We performed a randomized control trial among individuals who picked up a fecal immunochemical test (FIT) kit for colorectal cancer screening at the pharmacy but did not return it within 14 days. The intervention group (n=4563) received an SMS text message reminder on the 14th day of kit pick up and the control group (n=4806) received no reminder. A 30-day reminder letter was sent to both groups if necessary. The main primary outcome was the FIT completion rate within 30, 60, and 126 days from FIT kit pick up (intention-to-treat analysis). A telephone survey assessed the acceptability and appropriateness of the intervention. The cost-effectiveness of adding an SMS text message reminder to FIT completion was also performed.

Results: The intervention group had higher FIT completion rates than the control group at 30 (64.2% vs 53.7%; P<.001), 60 (78.6% vs 72.0%; P<.001), and 126 (82.6% vs 77.7%; P<.001) days. Participation rates were higher in the intervention arm independent of sex, age, socioeconomic level, and previous screening behavior. A total of 339 (89.2%) interviewees considered it important and useful to receive SMS text message reminders for FIT completion and 355 (93.4%) preferred SMS text messages to postal letters. We observed a reduction of US $2.4 per participant gained in the intervention arm for invitation costs compared to the control arm.

Conclusions: Adding an SMS text message reminder to the standard procedure significantly increased FIT kit return rates and was a cost-effective strategy. SMS text messages also proved to be an acceptable and appropriate communication channel for cancer screening programs.

Trial Registration: ClinicalTrials.gov NCT04343950; https://www.clinicaltrials.gov/study/NCT04343950

International Registered Report Identifier (IRRID): RR2-10.1371/journal.pone.0245806

JMIR Public Health Surveill 2024;10:e57959

doi:10.2196/57959

Keywords



Decreasing the burden of colorectal cancer (CRC) is a public health priority in most high-income countries [1]. In 2020, CRC was the third most common cancer in men and the second most common in women in Europe, with approximately 191,053 new cases in men and 150,366 in women. Moreover, CRC was also the second leading cause of cancer death in men, accounting for 87,185 deaths and the third in women, with 68,920 deaths [2]. Although different screening strategies exist, CRC screening programs using self-administered fecal occult blood test kits effectively reduce CRC mortality [3]. The Council of the European Union has recently published a new EU approach to cancer screening, replacing Council Recommendation 2003/878/EC. The new approach recommends a quantitative fecal immunochemical test (FIT) as the preferred test for CRC screening (2022/C 473/01) [4]. Participation in colorectal screening programs varies substantially throughout Europe from 11.6% to 67.7% [5]. To boost participation, the European Quality Guidelines for Quality Assurance in CRC screening and diagnosis recommends a reminder letter mailed to all nonattenders and states that although more effective than other modalities, phone reminders may not be cost-effective [6]. Moreover, new strategies and communication channels for improving participation among the target population of such programs need to be investigated.

Mobile phone SMS text messages are the most commonly used mobile health (mHealth) technology [7]. They offer instant transmission without being intrusive and lower costs compared to other communication channels [8,9]. SMS text message reminders have shown effectiveness in increasing mammography attendance in breast cancer screening and the European Commission Initiative for Breast Cancer now recommends its implementation in screening programs [10]. In CRC screening, SMS text message reminders to improve participation have shown moderate effects [7,9,11-13].

Catalonia (Spain) launched its CRC screening program in 2000, which provides free screening for men and women aged 50-69 years using a FIT. The program is operated by 11 screening hubs, most using a pharmacy-based model to distribute and collect the FIT kits [14]. Although global participation remains low among individuals who pick up the FIT kit at the pharmacy, compliance with FIT completion is high (93.5%) [15]. However, a nonnegligible percentage of individuals who collect the FIT kit at the pharmacy do not return it (6.5%). The design of a targeted intervention that considers individual stages of change is more effective than a single intervention that does not take into account specific population needs [16]. The Precaution Adoption Process Model (PAPM) is a useful framework for understanding CRC screening behavior because it recognizes different types of nonparticipants, such as those who are unaware, unengaged, undecided, decided not to get screened, or decided to get screened but did not. The PAPM also emphasizes the importance of turning intention into action, which is why reminders may be an effective intervention in bridging the intention-behavior gap [17].

Implementing an SMS text message intervention targeting individuals who decided to take action by going to the pharmacy to pick up a FIT kit may optimize the return rate and indirectly increase the overall participation in CRC screening.

This study assessed the effectiveness and acceptability of targeted SMS text message reminders for individuals who picked up but did not return their FIT kit within 14 days. Furthermore, a simple cost-effectiveness analysis of adding an SMS text message reminder to FIT completion was performed.


Design

A randomized controlled trial was conducted between June 30 and November 5, 2021, to compare the effectiveness of adding an SMS text message FIT return reminder to the standard FIT reminder procedure (a letter sent by postal mail). This trial is part of the Mobile phone messaging as a Tool to Improve Cancer Screening (M-TICS) study, with the protocol previously published [18] according to the Standard Protocol Items: Recommendations for Interventional Trials statement [19]. Embedded in the trial was a process evaluation using a telephone questionnaire exploring the acceptability of the intervention on a sample of trial participants.

Setting

The Catalan Institute of Oncology manages the screening hub of the northern and southern metropolitan areas of Barcelona, which is part of the Catalan CRC screening program (Spain). The hub covers a target population of 502,348 men and women aged 50-69 years (January 1, 2020) from the northern and southern metropolitan areas of Barcelona. The hub identifies individuals due for screening from the Central Register of Insured Persons of the Catalan Health Service. All eligible individuals receive an invitation letter to pick up a FIT kit at any pharmacy participating in the CRC program. In the sixth week, a reminder invitation letter is sent to nonrespondents. Individuals who picked up but did not return their FIT kit after 30 days receive an additional reminder letter to complete and return it. Community pharmacies send completed FIT kits to their allocated laboratory to be processed. Individuals with positive FIT results are offered a diagnostic colonoscopy.

Participants and Randomization

Eligible individuals were individuals who picked up but did not return their FIT kit at the pharmacy within 14 days. Simple randomization was performed to allocate the participants. An outsourcing company (Setting SL) designed an application using JavaScript’s built-in Math.random function to select and randomize eligible individuals in a 1:1 ratio to the intervention or control arm. From 30, June 2021, onward, eligible individuals were randomized to the intervention daily until the target sample size was achieved. Individuals without a registered mobile phone were excluded. Neither study participants nor investigators or data analysts were blinded to the intervention. However, the end point of this study did not require subjective judgment.

Intervention Description

Individuals randomly assigned to the intervention arm received an SMS text message reminder to return their FIT kit on day 14 after picking it up. Individuals randomly assigned to the control arm received no SMS text message reminder at this point. In both arms, participants still received the program’s standard reminder letter if they had not completed the FIT kit 30 days after picking it up. Individuals could request a new FIT kit by contacting the screening hub if they had lost it.

SMS text messages were bidirectional (enabled 2-way messaging) with fully automated delivery through a platform. The screening hub staff managed the incoming individual responses. The research team developed the SMS text message based on previous studies that suggested informative, short, and simple messages can increase screening rates [20-22]. It was previously tested in a convenience sample before the trial. The text of the message did not include individual data and the telephone number of the screening office was provided to resolve any concerns (Multimedia Appendix 1).

Process Evaluation

A subset of trial participants from both arms was recruited using consecutive sampling between October and November 2021. Participants were invited to respond to a brief structured telephone survey 2 weeks after the intervention. All calls were made during office hours (8-15 hours). The questionnaire comprised 9 items addressing the perceived acceptability and appropriateness of the intervention. Those who confirmed receiving the reminder were also asked about the understandability of the SMS text message.

Outcomes and Baseline Variables

The primary outcome of this study was the FIT completion rates at different time points of the screening process after the FIT pick up—at 30 days to assess the effect of sending an SMS text message (intervention group) compared to no SMS text message (control group), at 60 days to assess the effect of sending 2 reminders (SMS text message and reminder letter) in the intervention group and at 126 days to evaluate the overall participation at the end of the screening episode. Secondary outcome measures were user response time (time to FIT completion) and the number of FIT kits needed to complete a screening episode. Baseline variables were sex, age at the time of invitation, previous round screening behavior (participant or not), and Catalan tertiles of deprivation score index based on the individual’s primary health care area) [23].

Sample Size

Calculations were made to detect differences in participation among intervention and control groups. We estimated that 15% of individuals will not have a mobile phone registered and 10% of phone numbers will be wrongly recorded. Using these estimates and considering a 2-sided α of 5% and a power of 90%, we established that a sample of 10,174 individuals (5087 individuals in each group) would be needed to detect a 3% difference in participation between the intervention and control groups (69.4% vs 66.4%). These estimations were based on retrospective data from our screening database (2018). For the process evaluation survey, a sample size of 638 participants was estimated by considering a population percentage of 85% of SMS text message appropriateness, with a 95% confidence, a precision of +/– 3% point units and assuming that 20% of the individuals could not be contacted.

Cost-Effectiveness of Adding a Text Message to FIT Completion

The intervention arm costs were estimated by calculating the cost of sending an SMS text message (US $0.05) to individuals who collected the FIT kit but had not completed it in 14 days, plus the cost of sending a letter (US $0.55) at 30 days for individuals who had not yet completed the FIT kit at this point. The costs for the control arm were estimated by calculating the cost of sending a reminder letter to individuals who had not yet responded at 30 days. Incremental costs were, therefore, determined as the difference between the cost for the intervention arm and the control arm. Participation in CRC cancer screening at 126 days was considered the unit of benefit (effectiveness) in each arm. Therefore, the effect on incremental participation was calculated as the difference in participation between the intervention arm and the comparator arm. The incremental cost-effectiveness ratio was defined as the ratio of incremental cost to incremental effect.

Statistical Analyses

Baseline characteristics of the control and intervention arms were compared to identify imbalances in covariates during randomization. Continuous variables were analyzed using the Student t test and categorical variables using chi-square tests. The primary study outcome (FIT completion rate within 30 days, 60 days, and 126 days from FIT pickup date) was assessed on an intention-to-treat basis. Time-to-event analysis was conducted from the intervention date (date of the SMS text message) and FIT completion date. Time to FIT completion was described using Kaplan-Meier estimates and differences were tested using the log-rank test. Associations of the assigned arm with FIT completion status were assessed using a Cox proportional hazards model adjusted for the potential confounders, including sex, age, previous screening, and deprivation score index [15,24]. Results were reported as hazard ratios and 95% CIs. Process evaluation survey responses were synthesized using descriptive statistics.

All statistical tests were 2-tailed, with P<.05 considered significant. All the analyses were performed using STATA (version 17.0; StataCorp).

Ethical Considerations

The study received ethical approval from the Ethics Committee of the Bellvitge University Hospital, L’Hospitalet del Llobregat, Spain (reference PR042/20), which deemed that informed consent from the participants was not needed because the study was embedded in a routine screening service. However, for the telephone survey, verbal informed consent was obtained from each respondent. The study was performed in accordance with Good Clinical Practice and the Declaration of Helsinki. The CRC screening program follows general public health and data protection regulations [25-27] and accomplishes specific protocols based on the existing guidelines [28]. Confidentiality and privacy were ensured by collecting minimal personal information for recruitment purposes and this information was stored in a password-protected database. All data collected in the trial were deidentified and stored in a password-protected database. There was no compensation for the participants.


Characteristics of the Study Population

Between June and November 2021, the number of individuals who were enrolled in this study was 10,369. A total of 1000 (9.6%) individuals with no mobile phone number registered were excluded from the trial. Of the 9369 individuals included, 4806 were randomly allocated to the control arm and 4563 to the SMS text message reminder arm. SMS text messages failed to be delivered in 100 (2.2%) individuals assigned to the intervention group but were still included in the intention-to-treat analysis. In addition, 11 individuals in the control arm and 15 in the intervention arm who returned the FIT kit between data extraction and SMS text message delivery were also included (Figure 1).

The sample included 4792 (51.2%) women, the mean (SD) age was 57.6 (5.6) years, 5584 (59.9%) individuals were from a low deprivation area and 5248 (56.0%) had a previous screening test. Baseline characteristics were similar in both groups (Table 1).

Figure 1. The CONSORT (Consolidated Standards of Reporting Trials) flow diagram of reminder intervention to complete the FIT in a CRC screening program. CRC: colorectal cancer; FIT: fecal immunochemical test.
Table 1. Participants’ baseline characteristics by trial arm.

Intervention (n=4563), n (%)Control (n=4806), n (%)P valueTotal, n (%)
Sex.32

Female2310 (50.6)2482 (51.6)
4792 (51.2)

Male2253 (49.4)2324 (48.4)
4577 (48.9)
Age groups (years).50

50-593084 (67.6)3219 (67.0)
6303 (67.3)

60-691479 (32.4)1587 (33.0)
3066 (32.7)
Deprivation score.53

First tertile2696 (59.1)2888 (60.1)
5584 (59.6)

Second tertile1078 (23.6)1124 (23.4)
2202 (23.5)

Third tertile789 (17.3)794 (16.5)
1583 (16.9)
Previous screening.65

No2018 (44.2)2103 (43.8)
4121 (44.0)

Yes2545 (55.8)2703 (56.2)
5248 (56.0)

FIT Completion Rates

At 30 days of FIT pick up, a 10% absolute increase in the FIT completion rate was observed in individuals in the intervention arm compared to the control arm (64.2% vs 53.7%, respectively). After accounting for those in both arms who received the standard reminder letter for not returning the FIT kit within 30 days of picking it up, the intervention arm still showed an absolute FIT completion rate increase of 6.6% and 4.8% at 60 days and 126 days, respectively (Table 2). Subgroup analysis by sex, age, socioeconomic level, and screening profiles (previously screened or unscreened individuals) consistently showed higher participation rates in the intervention arm (Multimedia Appendices 2 and 3).

The Cox proportional hazards regression model adjusted by sociodemographic characteristics demonstrated that the intervention arm was associated with FIT completion (hazard ratio 1.21, 95% CI 1.16-1.27; Table 3).

Table 2. FITa completion rates and absolute differences within 30, 60, and 126 days of picking it up at the pharmacy by trial arm.

Intervention (n=4563), n (%)Control (n=4806), n (%)Absolute difference in FIT completion rate, points (95% CI)P value
Within 30 days2928 (64.2)2580 (53.7)10.5 (8.5-12.5)<.001
Within 60 days3587 (78.6)3461 (72.0)6.6 (4.9-8.3)<.001
Within 126 days3767 (82.6)3736 (77.7)4.8 (3.2-6.4)<.001

aFIT: fecal immunochemical test.

Table 3. Cox Proportional Hazards Regression Models of the effect of the SMS text message reminder adjusted by sociodemographic characteristics at 30, 60, and 126 days of picking the FITa kit up at the pharmacy.

FIT completion within 30 days, adjusted HRb (95% CI)FIT completion within 60 days, adjusted HR (95% CI)FIT completion within 126 days, adjusted HR (95% CI)
Intervention

ControlRef.cRef.Ref.

SMS1.27 (1.21-1.34)1.23 (1.18-1.29)1.21 (1.16-1.27)
Sex

MaleRef.Ref.Ref.

Female1.12 (1.06-1.18)1.10 (1.05-1.16)1.10 (1.05-1.15)
Age groups (years)

50-59Ref.Ref.Ref.

60-691.06 (1.00-1.12)1.05 (1.00-1.10)1.04 (0.99-1.09)
Deprivation score

First tertileRef.Ref.Ref.

Second tertile1.02 (0.96-1.09)0.99 (0.94-1.05)1.00 (0.95-1.06)

Third tertile0.97 (0.90-1.04)0.97 (0.91-1.04)0.97 (0.91-1.03)
Previous screening

NoRef.Ref.Ref.

Yes1.68 (1.59-1.78)1.76 (1.68-1.85)1.81 (1.72-1.90)

aFIT: fecal immunochemical test.

bHR: hazard ratio.

cRef.: reference category

Time to FIT Completion

The 90th percentile for FIT return time was reduced by 7 days in the intervention arm (48 days) compared to the control arm (55 days). Figure 2 displays the Kaplan-Meier curve on FIT completion by intervention, showing that the time to FIT completion in the intervention arm was significantly shorter than in the control arm (P<.001).

Figure 2. Kaplan-Meier curves on the time to FIT completion (days) since pick up by intervention and control arm. FIT: fecal immunochemical test.

Number of FITs

The number of FITs used to complete a screening episode did not differ between the trial and control arms (P=.99). Of the 3736 individuals in the control arm who completed screening, 3568 (95.5%) used 1 FIT and 168 (4.5%) required 2 FITs. Of the 3736 individuals in the intervention arm who completed screening, 3600 (95.6%) used 1 FIT and 167 (4.4%) required 2 FITs.

Acceptability and Appropriateness of the Intervention

Of the 646 individuals contacted by phone for the process evaluation survey, 415 (64.2%) were interviewed. The final sample size was smaller than planned (n=517) representing an increase of the margin of error from 3% to 3.37%. Most interviewed participants stated they would like to receive SMS text message notifications from the screening program, particularly if this was a reminder to complete and return their FIT (359/415, 86.5%). Most interviewees reported that receiving an SMS text message reminder to complete and return their FIT was important and useful (339/380, 89.2%) and almost all participants stated that they would prefer to receive the reminder via SMS text message rather than a letter (355/380, 93.4%). When asked to confirm if they recently received an SMS text message from the screening program, about 6 out of 10 respondents assigned to the intervention arm responded affirmatively (132/211). A total of 132 (100%) respondents who received the SMS reported that the content of the message and what they had to do was clear. In addition, almost all respondents reported having understood who was sending the SMS text message (121/132, 91.7%; Table 4).

Table 4. Survey results on the acceptability and appropriateness of receiving an SMS text message notification from the screening program.

Intervention (n=211), n (%)Control (n=204), n (%)All (n=415), n (%)
Would you like to receive any SMS text message notifications from the CRCa screening program?

Yes184 (87.2)170 (83.3)354 (85.3)

No0 (0.0)5 (2.5)5 (1.2)

Indifferent27 (12.8)29 (14.2)56 (13.5)
In particular, would you like to receive an SMS text message reminding you to return the FITb kit to the pharmacy?

Yes186 (88.2)170 (83.3)356 (85.8)

No25 (11.8)31 (15.2)56 (13.5)

Indifferent0 (0.0)3 (1.5)3 (0.7)
Do you think it would be important to receive an SMS text message to remind you to return the test to the pharmacyc?

Yes183 (94.3)163 (87.6)346 (91.1)

No11 (5.7)22 (11.8)33 (8.7)

Indifferent0 (0.0)1 (0.5)1 (0.3)
Do you think it would be useful to receive an SMS text message to remind you to return the test to the pharmacyc?

Yes183 (94.3)170 (91.4)353 (92.9)

No11 (5.7)14 (7.5)25 (6.6)

Indifferent0 (0.0)1 (0.5)1 (0.3)

Missing0 (0.0)1 (0.5)1 (0.3)
How would you prefer to be reminded to return the test, by letter or SMS text messagec?

SMS text message176 (90.7)158 (84.9)334 (87.9)

Letter7 (3.6)13 (7.0)20 (5.3)

Indifferent9 (4.6)12 (6.5)21 (5.5)

No reminder2 (1.0)1 (0.5)3 (0.8)

Do not know0 (0.0)2 (1.1)2 (0.5)
Have you recently received a reminder to return the FIT kit at the pharmacy?

Yes, an SMS text message132 (62.6)6 (2.9)138 (33.3)

Yes, a letter23 (10.9)21 (10.3)44 (10.6)

No48 (22.7)170 (83.3)218 (52.5)

Do not remember8 (3.8)5 (2.5)13 (3.1)

Missing0 (0.0)2 (1.0)2 (0.5)
Was the content of the message you received cleard?

Yes132 (100.0)N/Ae137 (33.0)

No0 (0.0)N/A0 (0.0)

Do not remember0 (0.0)N/A1 (0.2)
Did you understand what you had to do (was it clear what you had to do)d?

Yes132 (100.0)N/A137 (33.0)

No0 (0.0)N/A0 (0.0)

Do not remember0 (0.0)N/A1 (0.2)
Was it clear who was sending you the messaged?

Yes121 (91.7)N/A124 (29.9)

No7 (5.3)N/A8 (1.9)

Do not remember3 (2.3)N/A5 (1.2)

aCRC: colorectal cancer.

bFIT: fecal immunochemical test.

cIndividuals who responded negatively to questions 1 and 2 were directed to question 6 onward (n=18 in the control and n=17 in the intervention arm).

dOnly for individuals that responded affirmatively to question 6.

eN/A: not applicable.

Cost-Effectiveness of Adding an SMS to FIT Completion

The cost-effectiveness results are summarized in Table 5. We estimate a reduction of US $2.4 per participant gained in the intervention arm compared to the standard reminder letter, despite fewer individuals. To extrapolate the results, if every arm had 1000 individuals, the intervention arm would have a total cost of US $2.9 less than the control arm and 48 more individuals would have completed the test. Therefore, the intervention is clearly cost-effective.

Table 5. Cost-effectiveness of the reminders to FITa completion for individuals who picked up the screening test at the pharmacy but did not return it after 14 days.
Trial armNonparticipants at 14 days, nSMS text message cost (US $)bNonparticipants at 30 days, nLetter cost (US $)Participants at 126 days, nTotal cost (US $)Cost per extra participant (US $)
Only letter4806None22261229.537361229.5Ref.c
SMS + letter4563$251.81635903.137671154.8–2.4

aFIT: fecal immunochemical test.

bInclude a 1.9% SMS text message replies, US $0.05 per SMS text message.

cRef.: reference category.


Principal Findings

This 2-arm randomized controlled trial has shown that targeted SMS text message reminders can be an effective and well-accepted strategy to improve FIT completion rates in population-based CRC screening programs, particularly among those requiring participants to collect and return FIT kits at community pharmacies.

Our intervention increased the FIT completion rate by 4.8 percentage points at 126 days compared to the control arm. Adding a targeted SMS text message reminder, in addition to the standard letter reminder, for the FIT completion would improve the overall participation in our program by 0.6 percentage points, given that around 6.5% of invitees pick up but do not finally return the FIT [15]. According to the estimates of 1 death prevented out of 647 participating individuals over 25 years of screening [29], increasing this percentage point of the screening participation rate in the about 13 million target population in Spain could save the lives of an additional 121 individuals over 25 years. Even without increasing participation, replacing letters with SMS text messages can have a positive effect in reducing costs for the screening program.

The SMS text message intervention, compared to the control intervention, has additionally resulted in a reduction of 7 days in the user’s response time to complete the screening of a part of the invitees. This is a crucial result, as the effectiveness of CRC screening is based on the periodic testing by FIT; thus, ensuring a 24-month time sequence between invitations is essential to ensure the benefits of screening [6]. In programs where people take the test at home, providing a short user response time to complete the test is particularly relevant.

Unexpectedly, sending an SMS text message 14 days after FIT pick up did not reduce the number of lost kits, and consequently, we did not observe any differences in the number of FITs used between the 2 arms. In addition, the majority of participants who took part in our process evaluation survey reported that receiving an SMS text message to complete and return their FIT would be important and useful. Almost all our survey respondents also indicated that they preferred this communication channel to the standard postal reminder letters.

Our study’s main strengths include a randomized design and prospective data collection, combining effectiveness and acceptability data. One key limitation of this study is that it was not possible to differentiate the effect of adding a targeted reminder to the standard screening procedure from the effect of delivering this reminder via SMS text message. Another limitation was that the intervention was limited to people with a recorded mobile phone number with the screening program. Although the percentage of individuals with a recorded mobile phone number with the program was very high, it is still important to note that people who do not own a mobile phone may be the most vulnerable and with the most difficulties in accessing health services. In such cases, it may be worth exploring alternative technologies, such as interactive voice response [30,31].

To the best of our knowledge, this is the first intervention study to test SMS text message reminders specifically targeting population subgroups of a screening program. Two studies conducted in the national screening programs in England and Israel tested different SMS text message reminders, which led to a marginal increase in fecal occult blood tests usage by 0.6% points [9] and 0.7%-1.8% points, respectively [32], but these were delivered to the total population of nonparticipants. Combining a range of targeted interventions addressed to several specific population subgroups instead of all nonparticipants would have the potential to further increase overall participation with its related potential benefits.

Previous studies have demonstrated that men from lower socioeconomic status tend to have lower participation rates in CRC screening programs [33-35]. However, our research findings show that sending an SMS text message reminder to those at a more advanced stage in adopting screening behavior can effectively increase participation rates, regardless of their sociodemographic characteristics. The increase in FIT completion rates among the individuals who received the SMS text message intervention was observed irrespective of sex, age group, socioeconomic level, or whether individuals had been previously screened.

CRC screening programs have traditionally communicated with their target population by letter. However, making better use of available mobile technology is essential for improving cancer screening programs, optimizing economic resources, and reducing the ecological footprint of population-based screening. Our study has shown high levels of perceived acceptability and appropriateness among our study participants, who also indicated that they would prefer to receive notifications from the CRC screening program via SMS text message rather than a postal letter. Further studies should evaluate the feasibility of using SMS text message reminders alone rather than as an additional intervention to the standard reminder letters. This could help determine the potential for SMS text message reminders to replace letter-based reminders as the standard procedure for reminders in specific populations.

Conclusions

Our findings support the use of more than 1 reminder at different time points to optimize FIT kit return rates in FIT-based screening programs. Moreover, our results may contribute to efforts to tailor them to specific population subgroups. Therefore, this is an excellent opportunity to implement strategies that use digital technologies, such as sending SMS text messages in screening programs. Although traditionally, the target population received invitations by post, the need to establish other means of communication is becoming increasingly evident. Switching the communication method of a screening program from paper to SMS text message will reduce both costs and ecological footprint.

Acknowledgments

This work was partially funded by the Instituto de Salud Carlos III (ISCIII )-Subdirección General de Evaluación and by FEDER funds/European Regional Development Fund (ERDF)—a way to build Europe (PI19/00226). We thank the the Research Centres of Catalonia (CERCA) Programme / Generalitat de Catalunya.

The members of the MTICS study group are Gemma Binefa, Montse Garcia (Principal Investigator), Núria Milà, Noemie Travier, Carmen Vidal, Núria Vives, Josep A Espinàs M José Pérez Lacasta, Gemma Ibáñez-Sanz, Guillermo Bagaria, and Albert Farré. We also thank Núria Quirós, Virtudes Guardiola, Maria Jose Ruiz, Nativitat Valera, and Àngels Ventura of the Cancer Screening Unit of the Catalan Institute of Oncology for their administrative support. We did not use any generative artificial intelligence technology in creating the text, figures, or other informational content of this study.

Data Availability

The data sets generated and analyzed during this study are available in the CORA research data repository [36].

Authors' Contributions

NV conducted the study intervention, contributed to the project management and supervision, and prepared the original draft. MG contributed to the conceptualization, funding acquisition, project management, supervision, review, and editing. GB, NT, and CV contributed to the conceptualization, review, and editing. AF, GIS, EPNG, MJPL, and JAP contributed to reviewing and editing the final manuscript.

Conflicts of Interest

The authors declare funding from Instituto de Salud Carlos III ISCIII, no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years, and no other relationships or activities that could appear to have influenced the submitted work.

Multimedia Appendix 1

Content of the text message and reminder letter to return the fecal immunochemical test (FIT) kit.

DOCX File , 28 KB

Multimedia Appendix 2

Fecal immunochemical test (FIT) completion rate among intervention and control arms by sociodemographic characteristics.

DOCX File , 20 KB

Multimedia Appendix 3

CONSORT-EHEALTH checklist (V 1.6.1).

PDF File (Adobe PDF File), 1358 KB

  1. Sugawara E, Nikaido H. Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli. Antimicrob Agents Chemother. Dec 2014;58(12):7250-7257. [FREE Full text] [CrossRef] [Medline]
  2. European Cancer Information System. European Union. URL: https://ecis.jrc.ec.europa.eu/ [accessed 2024-02-23]
  3. Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325(19):1978-1998. [CrossRef] [Medline]
  4. Council recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening replacing council recommendation 2003/878/EC 2022/C 473/01. EUR-Lex. URL: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022H1213(01) [accessed 2024-12-27]
  5. International Agency for Research on Cancer. Cancer screening in the European union. Report on the implementation of the council recommendation on cancer screening (second report). In: International Agency for Research on Cancer. Brussels. European Commission; 2017.
  6. European Commission. European guidelines for quality assurance in colorectal cancer screening and diagnosis. In: European Commission, Directorate-General for Health and Consumers, Executive Agency for Health and Consumers WHO. Luxembourg. Publications Office of the European Union; 2010.
  7. Schliemann D, Tan MM, Hoe WMK, Mohan D, Taib NA, Donnelly M, et al. mHealth interventions to improve cancer screening and early detection: scoping review of reviews. J Med Internet Res. 2022;24(8):e36316. [FREE Full text] [CrossRef] [Medline]
  8. Car J, Gurol-Urganci I, de Jongh T, Vodopivec-Jamsek V, Atun R. Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev. 2012;(7):CD007458. [FREE Full text] [CrossRef] [Medline]
  9. Hirst Y, Skrobanski H, Kerrison RS, Kobayashi LC, Counsell N, Djedovic N, et al. Text-message reminders in colorectal cancer screening (TRICCS): a randomised controlled trial. Br J Cancer. 2017;116(11):1408-1414. [FREE Full text] [CrossRef] [Medline]
  10. European guidelines on breast cancer screening and diagnosis. European Commission. 2022. URL: https://healthcare-quality.jrc.ec.europa.eu/ecibc/european-breast-cancer-guidelines [accessed 2024-12-01]
  11. Uy C, Lopez J, Trinh-Shevrin C, Kwon S, Sherman S, Liang P. Text messaging interventions on cancer screening rates: a systematic review. J Med Internet Res. 2017;19(8):e296. [CrossRef]
  12. Mohan G, Chattopadhyay SK, Ekwueme DU, Sabatino SA, Okasako-Schmucker DL, Peng Y, et al. Community Preventive Services Task Force. Economics of multicomponent interventions to increase breast, cervical, and colorectal cancer screening: a community guide systematic review. Am J Prev Med. 2019;57(4):557-567. [FREE Full text] [CrossRef] [Medline]
  13. Gruner LF, Amitay EL, Heisser T, Guo F, Niedermaier T, Gies A, et al. The effects of different invitation schemes on the use of fecal occult blood tests for colorectal cancer screening: systematic review of randomized controlled trials. Cancers (Basel). 2021;13(7):1520. [FREE Full text] [CrossRef] [Medline]
  14. Monroy M, Aliberas J, Espinàs J, Catalán A. Resultados de una cartera de servicios de salud pública en la farmacia comunitaria: cribado de cáncer de colon [Findings from a community pharmacy services portfolio of public health: colon cancer screening]. Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya. 2015. URL: https:/​/aquas.​gencat.cat/​web/​.content/​minisite/​aquas/​publicacions/​2015/​documents/​Resultados_cartera_serveis_salut_publica_2015.​pdf [accessed 2024-07-05]
  15. Vives N, Milà N, Binefa G, Travier N, Farre A, Vidal C, et al. Role of community pharmacies in a population-based colorectal cancer screening program. Prev Med. 2021;145:106420. [CrossRef]
  16. Prochaska J, Redding C, Evers K. The transtheoretical modelstages of change. In: Glanz K, Rimer BK, Viswanath K, editors. Health Behavior: Theory, Research, and Practice. US. Boston University School of Public Health; 2008:97-121.
  17. Weinstein N, Sandman PM. The precaution adoption process modelits application. In: DiClemente RJ, Crosby RA, Kegler MC, editors. Emerging Theories in Health Promotion Practice and Research: Strategies for Improving Public Health. San Francisco, USA. John Wiley and Sons; 2012:16-39.
  18. Vives N, Farre A, Ibáñez-Sanz G, Vidal C, Binefa G, Milà N, et al. Text messaging as a tool to improve cancer screening programs (M-TICS study): a randomized controlled trial protocol. PLoS One. 2021;16(1):e0245806. [FREE Full text] [CrossRef] [Medline]
  19. Chan A, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. [FREE Full text] [CrossRef] [Medline]
  20. Huf S, Kerrison RS, King D, Chadborn T, Richmond A, Cunningham D, et al. Behavioral economics informed message content in text message reminders to improve cervical screening participation: two pragmatic randomized controlled trials. Prev Med. 2020;139:106170. [CrossRef] [Medline]
  21. Soto M, Martinez-Gutierrez J, Momany M, Capurro D, Ciampi Spode F, Cea E, et al. Preferences of underserved chilean women on a mobile technology intervention for cervical cancer screening: qualitative study. JMIR Mhealth Uhealth. 2018;6(11):e196. [FREE Full text] [CrossRef] [Medline]
  22. Lakkis NA, Atfeh AMA, El-Zein YR, Mahmassani DM, Hamadeh GN. The effect of two types of SMS-texts on the uptake of screening mammogram: a randomized controlled trial. Prev Med. 2011;53(4-5):325-327. [CrossRef] [Medline]
  23. Colls C, Mias M, García-Altés A. A deprivation index to reform the financing model of primary care in Catalonia (Spain). Gac Sanit. 2020;34(1):44-50. [FREE Full text] [CrossRef] [Medline]
  24. Haas CB, Phipps AI, Hajat A, Chubak J, Wernli KJ. Time to fecal immunochemical test completion for colorectal cancer screening. Am J Manag Care. 2019;25(4):174-180. [FREE Full text] [Medline]
  25. Boletin Oficial del Estado. Low 33/2011, of October 4, 2011: General Law on Public Health. Spain. Boletin Oficial del Estado; 2011.
  26. Regulation (EU) 2016/679 of the European parliament and of the council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing directive 95/46/EC. Off J Eur Union Luxemburgo. 2016. URL: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2016:119:TOC [accessed 2020-07-31]
  27. Boletin Oficial del Estado. Organic Law 3/2018 of December 5, 2018, on personal data protection and guarantee of digital rights. Spain. Boletin Oficial del Estado; 2018.
  28. Advisory Board of the Colorectal Cancer Screening Program of the Catalan Director Plan of Oncology. Organizational and Operational Guidelines in the Catalan Program for Early Detection of Colorectal Cancer. Catalonia. Department of Health. Catalan Government; 2015.
  29. Lew J, St John DJB, Xu X, Greuter MJE, Caruana M, Cenin DR, et al. Long-term evaluation of benefits, harms, and cost-effectiveness of the national bowel cancer screening program in Australia: a modelling study. Lancet Public Health. 2017;2(7):e331-e340. [FREE Full text] [CrossRef] [Medline]
  30. Coronado GD, Rivelli JS, Fuoco MJ, Vollmer WM, Petrik AF, Keast E, et al. Effect of reminding patients to complete fecal immunochemical testing: a comparative effectiveness study of automated and live approaches. J Gen Intern Med. 2018;33(1):72-78. [FREE Full text] [CrossRef] [Medline]
  31. Deeds S, Schuttner L, Wheat C, Gunnink E, Geyer J, Beste L, et al. Automated reminders enhance mailed fecal immunochemical test completion among veterans: a randomized controlled trial. J Gen Intern Med. 2024;39(1):113-119. [CrossRef] [Medline]
  32. Hagoel L, Neter E, Stein N, Rennert G. Harnessing the question-behavior effect to enhance colorectal cancer screening in an mHealth experiment. Am J Public Health. 2016;106(11):1998-2004. [CrossRef] [Medline]
  33. Solís-Ibinagagoitia M, Unanue-Arza S, Díaz-Seoane M, Martínez-Indart L, Lebeña-Maluf A, Idigoras I, et al. Factors related to non-participation in the Basque Country colorectal cancer screening programme. Front Public Health. 2020;8:604385. [FREE Full text] [CrossRef] [Medline]
  34. Unanue-Arza S, Solís-Ibinagagoitia M, Díaz-Seoane M, Mosquera-Metcalfe I, Idigoras I, Bilbao I, et al. Inequalities and risk factors related to non-participation in colorectal cancer screening programmes: a systematic review. Eur J Public Health. 2021;31(2):346-355. [FREE Full text] [CrossRef] [Medline]
  35. Dressler J, Johnsen AT, Madsen LJ, Rasmussen M, Jorgensen LN. Factors affecting patient adherence to publicly funded colorectal cancer screening programmes: a systematic review. Public Health. 2021;190:67-74. [CrossRef] [Medline]
  36. Replication data for: effectiveness and acceptability of targeted text message reminders in colorectal cancer screening: a randomised controlled trial (M-TICS study). CORA Research Data Repository. URL: https://doi.org/10.34810/data1481 [accessed 2024-02-28]


CRC: colorectal cancer
FIT: fecal immunochemical test
mHealth: mobile health
M-TICS: Mobile phone messaging as a Tool to Improve Cancer Screening
PAPM: Precaution Adoption Process Model


Edited by G Eysenbach, A Mavragani; submitted 01.03.24; peer-reviewed by N Ribeiro, J McIntosh, T Lam, C Reitz; comments to author 09.04.24; revised version received 30.04.24; accepted 08.06.24; published 31.07.24.

Copyright

©Nuria Vives, Noemie Travier, Albert Farre, Gemma Binefa, Carmen Vidal, Maria Jose Pérez Lacasta, Gemma Ibáñez-Sanz, Ena Pery Niño de Guzmán, Jon Aritz Panera, Montse Garcia, M-TICS Research Group. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 31.07.2024.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.